RecruitingNot ApplicableNCT05499091

Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN


Sponsor

University Hospital, Angers

Enrollment

1,200 participants

Start Date

Oct 10, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Next generation sequencing (NGS) allows some better diagnostic results, particularly, in the rare diseases field. At a twenty five percent rate, those exams highlight some variants which are not yet described in human pathology. The relationship between a variant found inside a candidate gene and a pathology, is able to be confirmed by functional studies at a protein level. This study aims to build a biological collection to feed further functional studies to confirm the relationship between NGS identified variants, and the clinical signs and symptoms.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Skin biopsy, blood sample, urine sample for people with genetic disease and rare diseases. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESkin biopsy, blood sample, urine sample

blood samples, urine samples, skin samples.


Locations(1)

Centre Hospitalo-Universitaire d'Angers

Angers, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05499091


Related Trials